Biochemicals: A future path for textile production?
Submitted by:
Andrew Warmington
The use of renewable carbon from wood to produce biobased products will have a crucial
Three new labs for Azelis
Submitted by:
Andrew Warmington
Azelis has announced the opening of new laboratories within the space of a month. Each
Seqens announces China investment
Submitted by:
Andrew Warmington
Seqens is to make an investment of nearly RMB 300 million (€40 million) in three
CDMO supply chain issues ‘often overlooked’
Submitted by:
Andrew Warmington
CDMO supply chains “are potentially the biggest single risk to product resilience, yet they remain
Evonik sells site to ICIG
Submitted by:
Andrew Warmington
Evonik has agreed to sell its site at Niederkassel-Lülsdorf, Germany, and the associated cyanuric chloride
Harima to open myrcene plant
Submitted by:
Andrew Warmington
Japanese firm Harima has built its first myrcene facility at its site in Kakogawa. Myrcene
Dipharma completes R&D expansion
Submitted by:
Andrew Warmington
Italian CDMO Dipharma Francis has completed of the expansion of its R&D centre for small
Singapore advance for Brenntag
Submitted by:
Andrew Warmington
Brenntag has opened its new pharmaceutical application development centre in the Singapore Science Park. This
Event preview - CPHI North America 2023: At the heart of the world’s largest pharma market
Submitted by:
Andrew Warmington
The CPHI Content Team takes a look ahead at the key event in the pharma
Solutions for solvent sustainability
Submitted by:
Andrew Warmington
Paul Vanden Branden, director and product manager at laboratory equipment supplier SciMed, examines the